Repressing either KLF6 or PDGFB impaired mTORC1 activity, whereas supplementing the KLF6-repressed cells with recombinant human PDGFB re-activated the mTORC1 signalling pathway in ccRCC [32]. Here, KLF6 is linked to nonpapillary renal cell carcinoma.